Free Trial

Baxter International (BAX) Competitors

Baxter International logo
$27.89 -0.48 (-1.70%)
Closing price 03:59 PM Eastern
Extended Trading
$27.84 -0.04 (-0.15%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BAX vs. AMN, DVA, BDX, EW, IDXX, RMD, DXCM, STE, PODD, and HOLX

Should you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include AMN Healthcare Services (AMN), DaVita (DVA), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), and Hologic (HOLX). These companies are all part of the "medical" sector.

Baxter International vs. Its Competitors

AMN Healthcare Services (NYSE:AMN) and Baxter International (NYSE:BAX) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings, media sentiment and risk.

Baxter International has a net margin of -4.71% compared to AMN Healthcare Services' net margin of -5.80%. Baxter International's return on equity of 17.24% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services-5.80% 13.39% 4.17%
Baxter International -4.71%17.24%5.12%

AMN Healthcare Services currently has a consensus target price of $32.08, indicating a potential upside of 57.96%. Baxter International has a consensus target price of $36.38, indicating a potential upside of 30.44%. Given AMN Healthcare Services' higher possible upside, equities research analysts clearly believe AMN Healthcare Services is more favorable than Baxter International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
1 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25
Baxter International
1 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.44

AMN Healthcare Services has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.98B0.26-$146.98M-$4.33-4.69
Baxter International$10.64B1.35-$649M-$1.10-25.35

AMN Healthcare Services has a beta of 0.18, meaning that its share price is 82% less volatile than the S&P 500. Comparatively, Baxter International has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500.

In the previous week, Baxter International had 8 more articles in the media than AMN Healthcare Services. MarketBeat recorded 14 mentions for Baxter International and 6 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.77 beat Baxter International's score of 0.29 indicating that AMN Healthcare Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Baxter International
3 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 0.9% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 0.2% of Baxter International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Baxter International beats AMN Healthcare Services on 10 of the 16 factors compared between the two stocks.

Get Baxter International News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAX vs. The Competition

MetricBaxter InternationalMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$14.56B$10.32B$5.57B$20.75B
Dividend Yield2.40%2.05%3.80%3.66%
P/E Ratio-25.3510.9619.8925.75
Price / Sales1.3529.26441.5059.30
Price / Cash5.9722.2635.8422.13
Price / Book2.033.618.264.66
Net Income-$649M$233.40M$3.24B$994.58M
7 Day Performance-5.90%-3.35%0.50%-0.69%
1 Month Performance-6.79%4.19%7.99%5.41%
1 Year Performance-21.91%-17.80%28.68%9.18%

Baxter International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAX
Baxter International
4.6071 of 5 stars
$27.89
-1.7%
$36.38
+30.4%
-20.1%$14.56B$10.64B-25.3538,000Dividend Announcement
Analyst Forecast
AMN
AMN Healthcare Services
4.3714 of 5 stars
$21.23
-3.1%
$32.08
+51.1%
-65.0%$812.68M$2.98B-4.902,968Analyst Revision
DVA
DaVita
4.507 of 5 stars
$142.71
+0.1%
$164.50
+15.3%
+1.8%$10.77B$12.82B14.1476,000Positive News
BDX
Becton, Dickinson and Company
4.7702 of 5 stars
$172.92
-1.8%
$219.22
+26.8%
-22.7%$49.56B$20.18B33.0074,000Analyst Revision
EW
Edwards Lifesciences
4.3804 of 5 stars
$76.64
-0.2%
$80.20
+4.6%
-13.2%$44.96B$5.44B10.9515,800Positive News
Upcoming Earnings
Analyst Forecast
IDXX
IDEXX Laboratories
3.6787 of 5 stars
$545.56
-0.3%
$558.11
+2.3%
+4.2%$43.87B$3.90B50.4211,000Positive News
Analyst Forecast
RMD
ResMed
4.2704 of 5 stars
$256.16
-0.3%
$259.33
+1.2%
+22.8%$37.56B$4.69B28.759,980Positive News
Analyst Upgrade
Analyst Revision
DXCM
DexCom
4.7888 of 5 stars
$82.94
+0.0%
$98.50
+18.8%
-27.5%$32.52B$4.03B61.9010,300Positive News
Analyst Forecast
STE
STERIS
4.8997 of 5 stars
$233.09
-1.9%
$263.83
+13.2%
-0.1%$22.93B$5.46B37.6017,787Positive News
Analyst Upgrade
Analyst Revision
PODD
Insulet
4.4912 of 5 stars
$300.70
-0.1%
$321.00
+6.8%
+43.1%$21.16B$2.20B54.083,900Analyst Revision
HOLX
Hologic
4.7141 of 5 stars
$64.37
-0.6%
$77.42
+20.3%
-18.6%$14.34B$4.03B27.167,063Positive News
Analyst Forecast

Related Companies and Tools


This page (NYSE:BAX) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners